MedTrace Logo

Assessment of the Safety and Efficacy of Pramipexole Extended Release in Patients With Parkinson's Disease in Routine Clinical Practice

NCT01061567 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1814

Last updated 2014-07-08

Study results available
· View outcomes & findings →

Summary

The general aim of this non-interventional study is to assess the safety and efficacy of pramipexole extended release in patients with Parkinson's disease in routine clinical practice.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Boehringer Ingelheim · Boehringer Ingelheim

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-11-30
Primary Completion
2013-06-30
Completion
2013-06-30

Countries

  • Austria
  • Estonia
  • Kazakhstan
  • Romania
  • Serbia
  • Slovakia
  • Slovenia

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01061567 on ClinicalTrials.gov